Zini Tanzi, Gina
 Distribuzione geografica
Continente #
EU - Europa 5.449
NA - Nord America 5.111
AS - Asia 3.492
SA - Sud America 698
AF - Africa 101
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.869
Nazione #
US - Stati Uniti d'America 4.960
DE - Germania 1.794
SG - Singapore 1.470
IT - Italia 1.411
CN - Cina 915
BR - Brasile 564
SE - Svezia 531
VN - Vietnam 359
FR - Francia 356
GB - Regno Unito 306
UA - Ucraina 291
IE - Irlanda 164
IN - India 142
ID - Indonesia 140
PL - Polonia 137
FI - Finlandia 135
RU - Federazione Russa 74
JP - Giappone 73
NL - Olanda 71
HK - Hong Kong 69
CA - Canada 67
AR - Argentina 54
TR - Turchia 54
MX - Messico 47
BE - Belgio 40
BD - Bangladesh 38
IQ - Iraq 37
IR - Iran 24
PK - Pakistan 23
ZA - Sudafrica 23
ES - Italia 21
AT - Austria 19
EC - Ecuador 19
SA - Arabia Saudita 17
PE - Perù 16
PT - Portogallo 15
CO - Colombia 14
LT - Lituania 14
MA - Marocco 14
AU - Australia 13
CH - Svizzera 13
CI - Costa d'Avorio 13
MY - Malesia 13
IL - Israele 12
PH - Filippine 12
JO - Giordania 11
KE - Kenya 11
AE - Emirati Arabi Uniti 10
KR - Corea 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
UZ - Uzbekistan 9
CL - Cile 8
RO - Romania 8
DZ - Algeria 7
EG - Egitto 7
JM - Giamaica 7
GE - Georgia 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EE - Estonia 5
GR - Grecia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LB - Libano 5
PY - Paraguay 5
YE - Yemen 5
BH - Bahrain 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
QA - Qatar 4
TW - Taiwan 4
AL - Albania 3
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
BZ - Belize 3
HN - Honduras 3
LV - Lettonia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
BY - Bielorussia 2
GH - Ghana 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SV - El Salvador 2
AD - Andorra 1
AZ - Azerbaigian 1
Totale 14.845
Città #
Singapore 738
Chandler 647
Ashburn 474
San Jose 414
Beijing 202
Jacksonville 195
San Mateo 174
Ann Arbor 169
Dublin 163
Milan 162
Rome 154
Dearborn 148
Nanjing 144
Los Angeles 133
Warsaw 114
Jakarta 112
Hanoi 107
Nürnberg 105
Ho Chi Minh City 104
New York 93
Lauterbourg 87
Munich 83
Dallas 82
Woodbridge 82
Cattolica 81
Wilmington 78
Frankfurt am Main 72
Boston 71
Lawrence 66
Houston 61
Redmond 60
Tokyo 60
Seattle 59
Fairfield 58
Bremen 55
Hong Kong 54
The Dalles 54
Nanchang 53
São Paulo 52
Redwood City 50
Hefei 49
Marseille 49
Lancaster 47
Moscow 39
Brussels 38
Naples 37
Helsinki 36
Hangzhou 35
Santa Clara 33
London 31
Izmir 29
Paris 29
Florence 28
Boardman 27
Norwalk 27
Bologna 26
Chicago 25
Leawood 25
Mountain View 25
Princeton 25
Shenyang 25
Toronto 25
Buffalo 24
Palermo 24
Rio de Janeiro 24
Zhengzhou 24
Turin 23
Brooklyn 22
Da Nang 22
Kunming 22
Shanghai 22
Tianjin 22
Turku 20
Cagliari 19
Guangzhou 19
Jiaxing 19
Orem 18
Augusta 17
Baghdad 17
Columbus 17
Hebei 17
Montreal 17
Düsseldorf 16
Pune 16
San Francisco 16
Haiphong 15
Las Vegas 15
Mexico City 15
Cambridge 14
Falls Church 14
Hyderabad 14
University Park 14
Abidjan 13
Chennai 13
Genoa 13
Johannesburg 13
Vienna 13
Amsterdam 12
Atlanta 12
Bari 12
Totale 7.239
Nome #
MORFOLOGIA DELLE MALATTIE DEL SANGUE Verduci Editore 1.199
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 382
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 366
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 341
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 297
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features 295
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 241
Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants 228
Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants 222
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 210
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization 202
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 198
Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors 194
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 194
Morphology of Blood Disorders 191
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 188
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 182
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 181
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 178
Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors 177
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 177
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 174
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 173
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 170
Allogeneic umbilical cord blood red cell concentrates: An innovative blood product for transfusion therapy of preterm infants 165
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 164
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 159
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 159
TWO-GROUP STUDY OF MEDIAL MICROSCOPY AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS 159
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 159
The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy 158
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 155
Transfusion of very low birth weight neonates using allogeneic cord blood derived RBC units. 155
Analysis of bone marrow aspiration fluid using automated blood cell counters. 154
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. 149
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 147
Allogeneic cord blood red cells for transfusion 143
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 140
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 139
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 139
Increased levels of solubile intercellular adhesion molecole-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary displasia. 134
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 134
Primary myelofibrosis: when the clone manifests with Rh phenotype splitting 132
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 132
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 132
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria 129
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 128
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 127
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 126
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes 121
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 121
Fechtner syndrome: report of a third family and literature review 119
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 117
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 115
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 114
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 114
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 113
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 112
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions 112
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial 111
the concomitance of lymphoma and breast carcinoma in the bone 111
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 107
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 106
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 105
Medicine use in pregnancy and public cord blood bank databases 104
Leukemia diagnosis: today and tomorrow 102
Inline extracorporeal photopheresis: evaluation of cell collection efficiency 100
Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film 99
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas 99
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 98
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 97
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 94
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 93
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance 92
The concomitance of lymphoma and breast carcinoma in the bone 92
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 91
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 90
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 87
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 86
Diagnostics and prognostication of myelodysplastic syndromes 86
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia 85
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets 84
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 84
CELL-BY-CELL ASSESSMENT OF MEDIAL MICROSCOPY (MM) AS A BETWEEN-OBSERVER TOOL FOR HARMONIZATION AND PROFICIENCY TESTING (ON BEHALF OF WP10 LEUKEMIANET DIAGNOSIS MORPHOLOGICAL FACULTY) 82
Innovation in hematology: Morphology and flow cytometry at the crossroads 77
Case of metastatic melanoma in bone marrow smear 76
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 73
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 70
Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients 68
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 67
ICSH: on board for new projects 67
Schistocytes 67
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 67
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 65
INTRODUCTION 61
Research in morphology and flow cytometry is at the heart of hematology 60
Totale 15.019
Categoria #
all - tutte 54.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022957 82 91 22 49 77 37 30 163 36 52 132 186
2022/20231.880 214 261 146 289 139 234 78 169 238 28 51 33
2023/2024970 55 253 33 64 48 142 86 26 23 37 105 98
2024/20252.075 45 72 150 100 222 98 98 99 281 208 402 300
2025/20264.465 721 136 268 409 702 245 843 229 288 344 178 102
Totale 15.019